Notice of extraordinary general meeting in Oasmia Pharmaceutical AB

NEXT STORY
Eurobio Scientific: Strong Earnings Growth for the First Half of 2019
PREV STORY
The Board of Directors in Oasmia proposes a rights issue of approximately SEK 400 million
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Multiple Abstracts Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) to be Presented at the American Headache Society’s 61st Annual Scientific Meeting

author_avatar
NASDAQ Market News

Crinetics Pharmaceuticals to Review 2020 Accomplishments and Provide 2021 Plans at 39th Annual J.P. Morgan Healthcare Conference 

author_avatar
NASDAQ Market News

NSU RECEIVES NATIONAL AWARD FOR DUAL DEGREE D.O./D.M.A. PROGRAM – FIRST IN THE COUNTRY

author_avatar
NASDAQ Market News